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 Fig. S1. Maximum likelihood tree determined on the basis of partial 16S rRNA gene sequences of 24 
Nostocales strains. Outgroup = Gloeobacter violaceaus (AF132790) (not shown). Strains from this study are 
marked in bold. Bootstrap values above 50 are included. The scale bar indicates 2% sequence divergence. 
Inset shows (A): Discoloration of the water turning orange caused by cyano-bacterial blooming (323104 
filaments/mL) (B). The bloom-forming species identified as C. raciborskii by16S rRNA gene sequences and 
its characteristic morphological feature (terminal heterocyst).
   
 
Figure S2. HPLC chromatograms of the partitionned extract: hypophase (A), and epiphase (B). 
(A): peak 7: major carotenoid glycoside (78.1 % purity) 
(B): peaks 1,2: chlorophyls, peak 5: β-cryptoxanthin, peak 6: echinenone, peak 7: (9/9’Z)-echinenone, peak 9: β-carotene, peak 10: (9Z)-β-carotene 
 
 
 Figure S3. HPLC chromatogram of the saponified epiphase. 
peak 3: β-cryptoxanthin, peak 4: echinenone, peak 5: (9/9’Z)-echinenone, peak 7: β-carotene, (9Z)-β-carotene 
 
 
  
Figure S4. HPLC chromatogram of the crystalline glycoside (peak 3, 99.9% purity) gained by OCC chromatography of the hypophase. 
 
  
Figure S5. HPLC chromatogram of the crystalline acetylated glycoside (peak 3, 95.2% purity). 
 
 Figure S6.a. 1H NMR spectrum of the acetylated glycoside in CDCl3. 
 Figure S6.b. 1H NMR spectrum of the acetylated glycoside in CDCl3. 
 Figure S6.c. 1H NMR spectrum of the acetylated glycoside in CDCl3. (*grease: long chain fatty acids) 
 Figure S7.a. 13C NMR spectrum of the acetylated glycoside in CDCl3. 
 Figure S7.b. 13C NMR spectrum of the acetylated glycoside in CDCl3. (*grease: long chain fatty acids) 
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Figure S8. COSY NMR spectrum of the acetylated glycoside in CDCl3. 
9 8 7 6 5 4 3 2 1 0
F2 Chemical Shift (ppm)
0
10
20
30
40
50
60
70
80
90
100
110
120
130
140
150
F
1
 C
h
e
m
ic
a
l 
S
h
if
t 
(p
p
m
)
 
Figure S9. HSQC NMR spectrum of the acetylated glycoside in CDCl3. 
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Figure S10. HMBC NMR spectrum of the acetylated glycoside in CDCl3. 
0.098 mg in 4 mL MeOH, c: 3.284E-5       0.098 mg 4 mL CHCl3, c: 3,28E-5 
  
0.098mg 4 mL Hexan, c: 3.28E-5       0.098 mg 4 mL Acetonitrile, c: 3.28E-5 
  
Figure S11. ECD spectrum of the acetylated glycoside in different solvents (cell width: 1 cm). 
 Figure S12. HRMS spectrum of the acetylated glycoside. 
 Figure S13. HRMS spectrum of the silylated glycoside. 
